Skip to main content

Table 5 Calculation of minimum detectable difference (MDD) for the mHealth Lakefolk Actively Keeping Engaged (mLAKE) trial

From: Impact of a community health worker HIV treatment and prevention intervention in an HIV hotspot fishing community in Rakai, Uganda (mLAKE): study protocol for a randomized controlled trial

Outcome

Control proportion

% Contamination

Control proportion + contamination

Intervention proportion

MDD ratio

MDD difference

PVP

0.112

0

0.112

0.066

0.593

−0.046

PVP

0.112

0.1

0.107

0.063

0.559

−0.049

PVP

0.112

0.2

0.101

0.059

0.524

−0.053

PVP

0.112

0.3

0.095

0.054

0.482

−0.058

PVP

0.112

0.4

0.087

0.048

0.433

−0.064

PVP

0.112

0.5

0.077

0.041

0.37

−0.071

HIV care coverage

0.801

0

0.801

0.92

1.149

0.119

HIV care coverage

0.801

0.1

0.814

0.934

1.147

0.12

HIV care coverage

0.801

0.2

0.831

0.952

1.145

0.121

HIV care coverage

0.801

0.3

0.854

0.976

1.144

0.122

HIV care coverage

0.801

0.4

NA

NA

NA

NA

HIV care coverage

0.801

0.5

NA

NA

NA

NA

ART coverage

0.797

0

0.797

0.952

1.195

0.155

ART coverage

0.797

0.1

0.814

0.971

1.193

0.157

ART coverage

0.797

0.2

0.837

0.997

1.191

0.16

ART coverage

0.797

0.3

NA

NA

NA

NA

ART coverage

0.797

0.4

NA

NA

NA

NA

ART coverage

0.797

0.5

NA

NA

NA

NA

MC coverage

0.669

0

0.669

0.822

1.229

0.153

MC coverage

0.669

0.1

0.686

0.842

1.227

0.156

MC coverage

0.669

0.2

0.709

0.869

1.225

0.16

MC coverage

0.669

0.3

0.739

0.904

1.222

0.164

MC coverage

0.669

0.4

0.783

0.955

1.219

0.172

MC coverage

0.669

0.5

NA

NA

NA

NA

HIV incidence

0.027

0

0.027

0.005

0.201

−0.021

HIV incidence

0.027

0.1

0.025

0.005

0.176

−0.022

HIV incidence

0.027

0.2

0.022

0.004

0.146

−0.023

HIV incidence

0.027

0.3

0.02

0.003

0.116

−0.024

HIV incidence

0.027

0.4

0.017

0.002

0.08

−0.025

HIV incidence

0.027

0.5

0.014

0.001

0.05

−0.025

  1. ART antiretroviral therapy, MC male circumcision, NA not applicable, PVP population viremia prevalence